TERAPET project is the result of a Research and Development Partnership between Politecnico di Milano’s Dipartimento di Elettronica, Informazione e Bioingegneria and Terapet, a privately held Swiss MedTech company developing innovative solutions for a safer, more precise, and time-saving proton therapy for cancer treatment.

The project will last for three years and it will be led by Prof. Carlo Fiorini and Prof. Marco Carminati of the RadLab, involving the development of high performance electronic devices (with ASIC and FPGA) for the detection and processing of gamma rays for proton therapy. The group will contribute to the dedicated electronics system development of Terapet’s first full-scale prototype to be installed for clinical validation.

Other three world-class research institutes are also involved in the development of Terapet’s first full-scale prototype: CERN, funded through the Innosuisse Innovation Project, and Karolinska Institute and the first Nordic Proton Therapy facility, Skandion Clinic, funded by Vinnova through the Eurostars Program.